Company
TRexBio
TRexBio is developing immunoregulatory medicines designed to restore immune balance in autoimmune and inflammatory diseases.
Also known as TRex Bio, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- South San Francisco, California, United States
- Legal name
- TRex Bio, Inc.
- trex.bio (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
TRexBio is developing immunoregulatory medicines designed to restore immune balance in autoimmune and inflammatory diseases. By addressing the disease where it presents, in the tissue, our goal is to promote tissue repair for more durable disease control.
Funding snapshot
- Total raised
- $50MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $50M2026-01-27
Funding rounds
- Round, 2026
- $50M2026-01-27, Company stated
Products
- Other
- TRB-061
- Other
- TRB-071
Loading relationship preview